X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (346) 346
humans (293) 293
male (187) 187
naphthyridines - adverse effects (169) 169
female (152) 152
naphthyridines - therapeutic use (145) 145
naphthyridines - pharmacology (122) 122
animals (120) 120
adult (119) 119
fluoroquinolones (117) 117
pharmacology & pharmacy (111) 111
middle aged (104) 104
naphthyridines - administration & dosage (91) 91
aged (79) 79
anti-infective agents - adverse effects (79) 79
naphthyridines - pharmacokinetics (58) 58
anti-infective agents - therapeutic use (57) 57
adolescent (52) 52
double-blind method (48) 48
treatment outcome (47) 47
gemifloxacin (46) 46
pharmacokinetics (44) 44
mice (40) 40
fluoroquinolones - adverse effects (39) 39
microbiology (39) 39
infectious diseases (38) 38
rats (38) 38
trovafloxacin (38) 38
administration, oral (34) 34
ciprofloxacin (34) 34
anti-infective agents - pharmacokinetics (33) 33
anti-infective agents - pharmacology (33) 33
fluoroquinolone (32) 32
anti-bacterial agents - adverse effects (31) 31
anti-infective agents - administration & dosage (31) 31
enoxacin (31) 31
aged, 80 and over (30) 30
anti-bacterial agents - therapeutic use (30) 30
dose-response relationship, drug (30) 30
drug interactions (28) 28
oncology (28) 28
fluoroquinolones - therapeutic use (27) 27
bacterial infections - drug therapy (26) 26
naphthyridines - chemistry (26) 26
safety (26) 26
abridged index medicus (24) 24
antibiotics (24) 24
levofloxacin (24) 24
microbial sensitivity tests (24) 24
streptococcus-pneumoniae (24) 24
child (22) 22
drug therapy (22) 22
in-vitro activity (22) 22
chemistry, medicinal (21) 21
clinical trials as topic (21) 21
community-acquired infections - drug therapy (21) 21
cross-over studies (21) 21
quinolone (21) 21
fluoroquinolones - administration & dosage (20) 20
efficacy (19) 19
medicine, general & internal (19) 19
toxicology (19) 19
drug administration schedule (18) 18
in-vitro (18) 18
anti-bacterial agents - administration & dosage (17) 17
anti-bacterial agents - pharmacology (17) 17
care and treatment (17) 17
cp-99,219 (17) 17
disease models, animal (17) 17
internal medicine (17) 17
naphthyridines - toxicity (17) 17
research (17) 17
analysis (16) 16
chronic disease (16) 16
drug therapy, combination (16) 16
naphthyridines - blood (16) 16
acute disease (15) 15
cancer (15) 15
child, preschool (15) 15
ofloxacin (15) 15
quinolones (15) 15
toxicity (15) 15
young adult (15) 15
apoptosis (14) 14
apoptosis - drug effects (14) 14
area under curve (14) 14
biochemistry & molecular biology (14) 14
clinical trials (14) 14
drug evaluation (14) 14
health aspects (14) 14
immunology (14) 14
naphthyridines - chemical synthesis (14) 14
pharmacology (14) 14
pneumonia (14) 14
pneumonia, bacterial - drug therapy (14) 14
time factors (14) 14
antimalarials - adverse effects (13) 13
article (13) 13
bay 94-8862 (13) 13
bronchitis - drug therapy (13) 13
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (339) 339
Japanese (17) 17
Chinese (4) 4
German (2) 2
Danish (1) 1
Polish (1) 1
Spanish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 10/2014, Volume 59, Issue 8, pp. 1083 - 1091
Background. Ceftriaxone is the foundation of currently recommended gonorrhea treatment. There is an urgent need for backup treatment options for patients with... 
Gemifloxacin | Neisseria gonorrhoeae | Gonorrhea treatment | Gentamicin | Azithromycin | INFECTIOUS DISEASES | CEFTRIAXONE | gemifloxacin | SUSCEPTIBILITY | RESISTANT NEISSERIA-GONORRHOEAE | GONOCOCCAL URETHRITIS | MICROBIOLOGY | azithromycin | IMMUNOLOGY | SEXUALLY-TRANSMITTED INFECTIONS | CEFIXIME | gonorrhea treatment | gentamicin | IN-VITRO ACTIVITY | Gastrointestinal Diseases - epidemiology | Naphthyridines - adverse effects | United States | Humans | Middle Aged | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - adverse effects | Gastrointestinal Diseases - pathology | Adult | Female | Anti-Bacterial Agents - adverse effects | Gentamicins - adverse effects | Gentamicins - therapeutic use | Administration, Oral | Fluoroquinolones - therapeutic use | Treatment Outcome | Injections, Intramuscular | Gonorrhea - drug therapy | Fluoroquinolones - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Azithromycin - adverse effects | Neisseria gonorrhoeae - isolation & purification | Drug Therapy, Combination - methods | Azithromycin - therapeutic use | Naphthyridines - therapeutic use | Adolescent | Gastrointestinal Diseases - chemically induced | Care and treatment | Dosage and administration | Gonorrhea | Risk factors | Antimicrobial agents | Effectiveness | Drug therapy | Drug resistance | Product safety | Index Medicus | and Commentaries
Journal Article
JAMA, ISSN 0098-7484, 09/2015, Volume 314, Issue 9, pp. 884 - 894
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 507, Issue 7492, pp. 329 - 334
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2013, Volume 34, Issue 31, pp. 2426 - 2428
This editorial refers to 'Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart... 
CARDIAC & CARDIOVASCULAR SYSTEMS | ALDOSTERONE | MYOCARDIAL-INFARCTION | HEART-FAILURE | Cardio-Renal Syndrome - drug therapy | Mineralocorticoid Receptor Antagonists - adverse effects | Female | Male | Naphthyridines - adverse effects | Humans | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 1, pp. e14501 - e14501
Background: New antimalarials are needed for P. vivax and P. falciparum malaria. This study compared the efficacy and safety of pyronaridine-artesunate with... 
ANTIMALARIAL-DRUG | THAILAND | EFFICACY | INDONESIA | UNCOMPLICATED FALCIPARUM-MALARIA | ARTEMETHER-LUMEFANTRINE | COMBINATION THERAPY | SUSCEPTIBILITY | BIOLOGY | RESISTANCE | ARTEMISININ | Naphthyridines - adverse effects | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Time Factors | Drug-Related Side Effects and Adverse Reactions | Adult | Female | Child | Antimalarials - adverse effects | Double-Blind Method | Artemisinins - administration & dosage | Chloroquine - therapeutic use | Treatment Outcome | Antimalarials - therapeutic use | Chloroquine - adverse effects | Fever | Malaria, Vivax - drug therapy | Naphthyridines - therapeutic use | Adolescent | Chloroquine - administration & dosage | Artemisinins - adverse effects | Naphthyridines - administration & dosage | Infection | Enzymes | Plasmodium falciparum | Care and treatment | Malaria | Antimalarials | Clinical trials | Dosage and administration | Rankings | Comparative analysis | Health aspects | Drugs | Haplotypes | Chloroquine | Liver | Erythrocytes | Infections | Parasites | Epidemiology | Incidence | Ethics | Hepatitis | Randomization | Safety engineering | Artesunate | Pharmaceutical industry | Vector-borne diseases | Medical research | Effectiveness | Internal medicine | Research & development--R&D | Patients | Medicine | Hospitals | Pyronaridine | Index Medicus | Research & development | R&D
Journal Article
EUROPEAN JOURNAL OF HEART FAILURE, ISSN 1388-9842, 02/2015, Volume 17, Issue 2, pp. 224 - 232
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 14, pp. 1298 - 1309
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2015, Volume 168, Issue 6, pp. 796 - 805
Journal Article